Clinical Cardiology Alert – December 1, 2004
December 1, 2004
View Issues
-
Late-Breaking Clinical Trials from the AHA Scientific Sessions
Arguably the most important new trial to be reported in New Orleans was the African-American Heart Failure Trial; the use of a combination of isosorbide dinitrate and hydralazine in African-Americans with congestive heart failure. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: ACE Inhibitors and Receptor Blockers: Which is Inferior?
The first head-to-head comparison study of an ACE inhibitor and an angiotensin receptor blocker, to assess renoprotective effects in type 2 diabetes, has shown that the drugs are comparable in their benefit.